Assessing the role of human recombinant hyaluronidase in gravity-driven subcutaneous hydration: The INFUSE-LR study

Journal of Palliative Medicine

Volumn 10, Issue 6, 2007, Pages 1312-1320

  Thomas, Jay R ^a   Yocum, Richard C ^b   Haller, Michael F ^b   Von Gunten, Charles F ^a  

^a Institute for Palliative Medicine at San Diego Hospice   (United States)

^b Halozyme Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIDASE; HYLENEX; PLACEBO; RECOMBINANT ENZYME; RECOMBINANT HYALURONIDASE; RINGER LACTATE SOLUTION; UNCLASSIFIED DRUG;

ADULT; ARM CIRCUMFERENCE; ARM EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; FLOW RATE; GRAVITY; HUMAN; HYDRATION; INJECTION SITE RASH; INJECTION SITE REACTION; INTRAVENOUS CATHETER; MALE; NORMAL HUMAN; PAPULAR RASH; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; CALIFORNIA; FEMALE; FLUID THERAPY; HUMANS; HYALURONOGLUCOSAMINIDASE; INFUSIONS, PARENTERAL; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PLACEBOS; RECOMBINANT PROTEINS;

EID: 35348821398     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2007.0126     Document Type: Article

References (25)

1. Soifer NE, Borzak S, Edlin BR, Weinstein RA: Prevention of peripheral venous catheter complications with an intravenous therapy team: Randomized controlled trial. Arch Intern Med 1998;158:473-477.
2. Kurul S, Saip P, Aydin T: Totally implantable venous-access ports: Local problems and extravasation injury. Lancet Oncol 2002;3:684-692.
3. Monreal M, Davant E: Thrombotic complications of central venous catheters in cancer patients. Acta Haematol 2001;106:69-72.
4. Sasson M, Shvartzman P: Hypodermoclysis: An alternative infusion technique. Am Fam Physician 2001;64:1575-1578.
5. Dasgupta M, Binns MA, Rochon PA: Subcutaneous fluid infusion in a long-term care setting. J Am Geriatr Soc 2000;48:795-799.
6. Challiner YC, Jarrett D, Hayward MJ, al Jubouri MA, Julious SA: A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients. Postgrad Med J 1994;70:195-197.
7. O'Keeffe ST, Lavan JN: Subcutaneous fluids in elderly hospital patients with cognitive impairment. Gerontology 1996;42:36-39.
8. Yap LK, Tan SH, Koo WH: Hypodermoclysis or subcutaneous infusion revisited. Singapore Med J 2001;42:526-529.
9. Fainsinger RL, MacEachern T, Miller MJ, Bruera E, Spachynski K, Kuehn N, Hanson J: The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 1994;9:298-302.
10. Macmillan K, Bruera E, Kuehn N, Selmser P, Macmillan A: A prospective comparison study between a butterfly needle and a Teflon cannula for subcutaneous narcotic administration. J Pain Symptom Manage 1994;9:82-84.
11. Frisoli JA, de Paula AP, Feldman D, Nasri F: Subcutaneous hydration by hypodermoclysis. A practical and low cost treatment for elderly patients. Drugs Aging 2000;16:313-319.
12. Rochon PA, Gill SS, Litner J, Fischbach M, Goodison AJ, Gordon M: A systematic review of the evidence for hypodermoclysis to treat dehydration in older people. J Gerontol A Biol Sci Med Sci 1997;52:M169-M176.
13. Hylenex Prescribing Information. Deerfield, IL: Baxter Healthcare Corporation, 2006.
14. Gaisford W, Evans DG: Hyaluronidase in paediatric therapy. Lancet 1949;2:505-507.
15. Food and Drug Administration. Federal Register 1970;35:14800-14801.
16. Lipschitz S, Campbell AJ, Roberts MS, Wanwimolruk S, McQueen EG, McQueen M, Firth LA: Subcutaneous fluid administration in elderly subjects: Validation of an underused technique. J Am Geriatr Soc 1991;39:6-9.
17. Constans T, Dutertre JP, Froge E: Hypodermoclysis in dehydrated elderly patients: local effects with and without hyaluronidase. J Palliat Care 1991;7:10-12.
18. Bruera E, Neumann CM, Pituskin E, Calder K, Hanson J: A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration. Ann Oncol 1999;10:1255-1258.
19. Ebo DG, Goossens S, Opsomer F, Bridts CH, Stevens WJ: Flow-assisted diagnosis of anaphylaxis to hyaluronidase. Allergy 2005;60:1333-1334.
20. Yocum RC, Kennard D, Heiner LS: Assessment and implication of the allergic sensitivity to a single dose of recombinant human hyaluronidase injection: A double-blind, placebo-controlled clinical trial. J Infus Nurs 2007;30:293-299.
21. Kelly AM: The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J 2001;18:205-207.
22. Peng B, Hayes M, Resta D, Racine-Poon A, Druker BJ, Talpaz M, Sawyers CL, Rosamilia M, Ford J, Lloyd P, Capdeville R: Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients. J Clin Oncol 2004;22:935-942.
23. Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S: Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: Proof-of-concept and proof-of-product studies. Arch Gen Psychiatry 2003;60:204-211.
24. Wiltshire H, Hirankarn S, Farrell C, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N: Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet 2005;44:495-507.
25. Bookbinder LH, Hofer A, Haller MF, Zepeda ML, Keller GA, Lim JE, Edgington TS, Shepard HM, Patton JS, Frost GI: A recombinant human enzyme for enhanced interstitial transport of therapeutics. J Control Release 2006;114:230-241.